Literature DB >> 3414785

Weight loss in obese mice persistently infected with lymphocytic choriomeningitis virus is not associated with elevated tumor necrosis factor/cachectin activity in peritoneal macrophages.

J L Lathey1, M B Oldstone.   

Abstract

C57BL/6 ob/ob (C57 ob/ob) mice infected persistently with lymphocytic choriomeningitis virus (LCMV) show cachexia as judged by a weight loss of greater than 20%. Virus persists in a subset of macrophages. Because a cachexic state occurs in several chronic debilitating diseases of humans, often accompanied by persistent microbial infections with macrophage/monocytic involvement and tumor necrosis factor (TNF) cachectin production, the role of TNF in the weightloss of ob/ob mice infected persistently with LCMV was investigated. TNF mRNA expression was not increased in peritoneal cells from such persistently-infected mice, nor did their serum levels of TNF rise above those in uninfected litter-mates. Furthermore, in vitro LCMV infection of adherent peritoneal cells from these C57 ob/ob mice did not enhance TNF mRNA or protein expression. Therefore, the cachexia-like weight loss observed in C57 ob/ob mice during a persistent LCMV infection is apparently not associated with a measurable increase in TNF.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3414785      PMCID: PMC1880743     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  22 in total

1.  Macrophage activation in mice infected with ectromelia or lymphocytic choriomeningitis viruses.

Authors:  R V Blanden; C A Mims
Journal:  Aust J Exp Biol Med Sci       Date:  1973-06

2.  Cytoplasmic dot hybridization. Simple analysis of relative mRNA levels in multiple small cell or tissue samples.

Authors:  B A White; F C Bancroft
Journal:  J Biol Chem       Date:  1982-08-10       Impact factor: 5.157

3.  Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin.

Authors:  D Pennica; G E Nedwin; J S Hayflick; P H Seeburg; R Derynck; M A Palladino; W J Kohr; B B Aggarwal; D V Goeddel
Journal:  Nature       Date:  1984 Dec 20-1985 Jan 2       Impact factor: 49.962

Review 4.  Interleukin 1, tumour necrosis factor-alpha (cachectin) and the pathogenesis of cancer cachexia.

Authors:  L L Moldawer; M Georgieff; K Lundholm
Journal:  Clin Physiol       Date:  1987-08

5.  Analysis of persistent virus infections by in situ hybridization to whole-mouse sections.

Authors:  P J Southern; P Blount; M B Oldstone
Journal:  Nature       Date:  1984 Dec 6-12       Impact factor: 49.962

6.  Lessons from studies with genetic forms of diabetes in the mouse.

Authors:  D L Coleman
Journal:  Metabolism       Date:  1983-07       Impact factor: 8.694

7.  Infection of cultivated mouse peritoneal macrophages with lymphocytic choriomeningitis virus.

Authors:  R Schwartz; J Löhler; F Lehmann-Grube
Journal:  J Gen Virol       Date:  1978-06       Impact factor: 3.891

8.  Cloning and expression of murine interleukin-1 cDNA in Escherichia coli.

Authors:  P T Lomedico; U Gubler; C P Hellmann; M Dukovich; J G Giri; Y C Pan; K Collier; R Semionow; A O Chua; S B Mizel
Journal:  Nature       Date:  1984 Nov 29-Dec 5       Impact factor: 49.962

9.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

10.  Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence.

Authors:  R Ahmed; A Salmi; L D Butler; J M Chiller; M B Oldstone
Journal:  J Exp Med       Date:  1984-08-01       Impact factor: 14.307

View more
  1 in total

1.  Gamma interferon signaling in macrophage lineage cells regulates central nervous system inflammation and chemokine production.

Authors:  Adora A Lin; Pulak K Tripathi; Allyson Sholl; Michael B Jordan; David A Hildeman
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.